NET PROFIT (x1000 EUR)
EMPLOYEES
Solural Pharma ApS
Closing information (x1000 EUR)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
815
|
399
|
50 |
| Total assets |
1,752
|
1,232
|
924 |
| Current assets |
1,608
|
1,106
|
866 |
| Current liabilities |
411
|
280
|
256 |
| Equity capital |
1,340
|
952
|
668 |
| - share capital |
11
|
11
|
11 |
| Employees (average) |
7
|
7
|
7 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
76.5%
|
77.3%
|
72.3% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
391.2%
|
395.0%
|
338.3% |
| Return on equity (ROE) |
60.8%
|
41.9%
|
7.5% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.